Navigation Links
CRH Medical Corp. Joins OTCQX

NEW YORK, Aug. 17 /PRNewswire-FirstCall/ -- Pink OTC Markets Inc. (OTCQX: PINK), the financial information and technology services company that operates the leading electronic quotation and trading system in the U.S. OTC securities market, today announced that CRH Medical Corp. (OTCQX: CRMMF, TSX.V: CRM), a Canadian-based medical technology company, is now trading on the OTC market's highest tier, OTCQX®.



CRH Medical began trading today on the OTC market's prestigious tier, OTCQX International. Investors can find current financial disclosure and Real-Time Level 2 quotes for the company on and

"OTCQX companies demonstrate their commitment to providing superior information to investors and maintaining the highest quality standards," said R. Cromwell Coulson, President and CEO of Pink OTC Markets. "We are pleased to welcome CRH Medical to OTCQX."

Berenbaum Weinshienk PC will serve as CRH Medical's Principal American Liaison ("PAL") on OTCQX, responsible for providing guidance on OTCQX requirements.

About CRH Medical Corp.

CRH Medical Corp. (OTCQX: CRMMF, TSX.V: CRM) specializes in the treatment of hemorrhoids utilizing its proven treatment protocol and patented proprietary technology.  CRH's single use, disposable, hemorrhoid technology is safe and highly effective in treating hemorrhoid grades I – IV.  CRH employs two commercialization strategies: first, CRH distributes its hemorrhoid banding technology, treatment protocols, operational and marketing expertise as a complete, turnkey package directly to its partner physicians ("Partnership Program"). In addition, CRH operates Centers for Colorectal Health facilities in the United States specializing in the treatment of hemorrhoids, fissures, and colon cancer screening.  The Company currently operates eight Centers geographically dispersed through the U.S. The Company's goal is to establish the CRH O'Regan System as the standard for hemorrhoid treatment.


The OTCQX Marketplace is the premier tier of the U.S. OTC market.  Investor-focused companies use the quality controlled OTCQX platform to offer investors transparent trading, superior information, and easy access through their regulated U.S. broker-dealers. The innovative OTCQX platform offers companies and their shareholders a level of marketplace services formerly available only on a U.S. stock exchange.  For more information and to view a full list of OTCQX companies, visit

About Pink OTC Markets Inc.

Pink OTC Markets Inc. (OTCQX: PINK) operates the leading electronic interdealer quotation and trading system for over 9,000 securities not listed on a U.S. stock exchange. Pink OTC Markets segments these securities into three tiers: the quality-controlled OTCQX marketplace, the U.S. registered and reporting OTCQB marketplace, and the speculative trading Pink Sheets marketplace. These three tiers constitute the third largest U.S. liquidity pool for trading public company shares, after The NASDAQ Stock Market, Inc. and The New York Stock Exchange. Our products and services promote market transparency, improve price discovery, facilitate regulatory compliance, and increase the quality of issuer disclosure, to the benefit of all OTC market participants.  To learn more about how Pink OTC Markets' products and services make OTC markets more transparent, informed, and efficient, please visit our websites at, and or contact us at

Subscribe to the OTCQX RSS Feed

SOURCE Pink OTC Markets Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Octapharma Grants Program Awards First Research Grant to Rush University Medical Center
2. ISMPP and MPIP Announce New Medical Publishing Website
3. Applications for the September ISMPP Certified Medical Publication Professional Exam Now Being Accepted
4. ISMPP Reiterates Progress in Medical Publications in Response to Senator Grassleys Report
5. New Procedures Consult Mobile From Elsevier Enables Clinicians to View Top Medical Procedures From Mobile Devices
6. NeoStem to Receive $700,000 from the U.S. Armys Medical Research and Materiel Command to Advance Adult Stem Cell Therapies in Treating Traumatic Wounds
7. Dehaier Medical Systems Reaffirms Earnings Estimate of $0.80 EPS for FY 2010
8. Dehaier Medical Systems Signs $1.6 Million Oxygen-Chip Sales Contract
9. Medical Simulation Corporation Partners with Hutchinson Technology in Training of Healthcare Professionals on Noninvasive Tissue Oxygenation Monitoring
10. Cardon Children's Medical Center Adopts TrueVision 3D Surgical Visualization Platform for Department of Pediatric Neurosurgery
11. Stemedica Announces the Appointment of Dr. Csar Amescua Garcia as Medical and Regulatory Affairs Director – Latin America
Post Your Comments:
(Date:11/25/2015)... ... 25, 2015 , ... Jessica Richman and Zachary Apte, founders ... initial angel funding process. Now, they are paying it forward to other microbiome ... investments in the microbiome space. In this, they join other successful entrepreneurs-turned-angels ...
(Date:11/24/2015)... , Nov. 24, 2015 Cepheid (NASDAQ: ... speaking at the following conference, and invited investors to ... NY      Tuesday, December 1, 2015 at 11.00 ... NY      Tuesday, December 1, 2015 at 11.00 ... Conference, New York, NY      Tuesday, ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... maintain healthy metabolism. But unless it is bound to proteins, copper is also ... Health (NIH), researchers at Worcester Polytechnic Institute (WPI) will conduct a systematic study ...
(Date:11/24/2015)... -- Clintrax Global, Inc., a worldwide provider of clinical research services headquartered ... the company has set a new quarterly earnings record in Q3 ... posted for Q3 of 2014 to Q3 of 2015.   ... , with the establishment of an Asia-Pacific ... United Kingdom and Mexico , with ...
Breaking Biology Technology:
(Date:11/17/2015)... , Nov. 17, 2015 Pressure BioSciences, Inc. ... the development and sale of broadly enabling, pressure cycling ... sciences industry, today announced it has received gross proceeds ... million Private Placement (the "Offering"), increasing the total amount ... or more additional closings are expected in the near ...
(Date:11/12/2015)... golden retriever that stayed healthy despite having the gene ... new lead for treating this muscle-wasting disorder, report scientists ... and Harvard and the University of São Paolo in ... pinpoints a protective gene that boosts muscle regeneration, ... Children,s lab of Lou Kunkel , PhD, is ...
(Date:11/12/2015)... Nov. 11, 2015   Growing need for ... tools has been paving the way for use ... of discrete analytes in clinical, agricultural, environmental, food ... predominantly used in medical applications, however, their adoption ... due to continuous emphasis on improving product quality ...
Breaking Biology News(10 mins):